Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $105.6300 (5.7%) ($105.6300 - $106.1550) on Wed. Mar. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.6% (three month average) | RSI | 36 | Latest Price | $105.6300(5.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -2.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(61%) IWO(61%) IWM(60%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.8% in a week (0% probabilities). VIXM(-27%) UUP(-21%) VXX(-17%) UNG(-5%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.8% (StdDev 3.6%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $85.93(-18.65%) | Resistance Level | $106.9 | 5 Day Moving Average | $100.25(5.37%) | 10 Day Moving Average | $100.72(4.87%) | 20 Day Moving Average | $106.9(-1.19%) | To recent high | -35.2% | To recent low | 10.8% | Market Cap | $1.698b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |